Susquehanna International Group Ltd. Compugen LTD Transaction History

Susquehanna International Group Ltd.

  • $390 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023
SELL
$0.57 - $1.38 $4,248 - $10,286
-7,454 Reduced 9.31%
72,612 $82,000
Q1 2023

May 16, 2023
BUY
$0.68 - $1.11 $54,444 - $88,873
80,066 New
80,066 $56,000
Q4 2021

Feb 14, 2022
SELL
$4.09 - $7.16 $65,174 - $114,094
-15,935 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$5.8 - $8.02 $92,423 - $127,798
15,935 New
15,935 $96,000

Others Institutions Holding CGEN

# of Institutions
73
Shares Held
13.1M
Call Options Held
79.2K
Put Options Held
12.7K
View Full List

About COMPUGEN LTD

CGEN Quotes by TradingView
  • Ticker CGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,624,600
  • Market Cap $131M
  • Description
  • Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...
More about CGEN
Track This Portfolio

Track Susquehanna International Group Ltd. Portfolio

Follow Susquehanna International Group Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email